from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2598/-

LFCtreatmentdescriptionclass of inhibitor

-0.614

Amikacinug/mL Amikacintranslation

-0.169

Cap5-10ug/mL Capreomycintranslation

1.697

Rox10-50 ug/mL Roxithromycintranslation

-0.563

SM2-5 ug/mL Streptomycintranslation

-1.017

Tet5-10 ug/mL Tetracyclinetranslation

0.357

Rif0.2-5ug/mL Rifampicintranscription

0.294

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.817

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.468

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.282

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.220

Clofazimine10-13 ug/mL Clofaziminerespiration

0.240

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.285

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.499

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.068

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.832

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.844

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.234

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.930

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.453

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.347

KCN5-20 ug/mL Potassium cyaniderespiration

0.597

NaN30.2-2 mM Sodium aziderespiration

-0.470

Nigericin50 uM Nigericinrespiration

-0.047

TRC10-150 ug/mL Triclosanrespiration

-0.454

TRZ10-25 ug/mL Thioridazinerespiration

-1.095

Valinomycin0.5-10 uM Valinomycinrespiration

-2.906

ZnSO42 mM ZnSO4respiration

-0.946

menadione6-10 ug/mL Menadionerespiration

-0.119

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.008

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.400

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.222

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.139

NRP_1Non-replicating persistence stage 1dosRassociated

-1.033

Amp0.2mg/mL AmpicillincellWall

0.139

Cephalexin20-100 ug/mL CephalexincellWall

-0.257

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.816

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.251

EMB10-20 ug/mL EthambutolcellWall

-0.784

Eta12-40 ug/mL EthionamidecellWall

-0.933

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.559

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.082

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.094

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.023

BZA0.12 mg/mL BenzamidearomaticAmides

0.019

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.271

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.023

H2O24 mM hydrogen peroxideDNAdamaging

0.587

Levo10 ug/mL LevofloxacinDNAdamaging

0.174

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.939

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.363

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.272

UVUV-irradiationDNAdamaging

0.807

ARP41-4 ug/mL Antitubercular compound ARP4?

0.102

Antimycin12.5-50 ug/mL Antimycin A?

-0.239

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.038

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.329

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.295

PA8240.2-2 ug/mL PA-824?

-0.414

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.151

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.451

Verapamil50 uM Verapamil?

0.069

mercaptoethanol2 mM 2-Mercaptoethanol?

0.744

methoxatin10-20 ug/mL Methoxatin?